NOVEN PHARMACEUTICALS INC (NOVN) is a publicly traded company in the Unknown sector. Across all available filings, 40 corporate insiders have executed 296 transactions totaling $48.8M, demonstrating a bullish sentiment with $7.4M in net insider flow. The most recent transaction on Jun 27, 2023 involved a sale of 11,553 shares valued at $4.7K.
No significant insider buying has been recorded for NOVN in the recent period.
No significant insider selling has been recorded for NOVN in the recent period.
Based on recent SEC filings, insider sentiment for NOVN is bullish with an Insider Alignment Score of 58/100 and a net flow of $7.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NOVEN PHARMACEUTICALS INC (NOVN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 40 insiders are actively trading NOVN stock, having executed 296 transactions in the past 90 days. The most active insider is Capital Management Oss (Executive), who has made 16 transactions totaling $15.6M.
Get notified when executives and directors at NOVN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | Sanders Machelle | Executive | Sale | 11,553 | $0.41 | $4.7K | |
| Jun 7, 2023 | D. Skolsky Steven | Executive | Option Exercise | 36,101 | $N/A | $0 | |
| Jun 7, 2023 | J. Keegan Robert | Executive | Option Exercise | 36,101 | $N/A | $0 | |
| Jun 7, 2023 | L. Bierman James | Executive | Option Exercise | 36,101 | $N/A | $0 | |
| Jun 7, 2023 | Sanders Machelle | Executive | Option Exercise | 36,101 | $N/A | $0 | |
| Jun 7, 2023 | Kent Geer W. | Executive | Option Exercise | 36,101 | $N/A | $0 | |
| Jun 7, 2023 | M. Gay John | Executive | Option Exercise | 65,000 | $N/A | $0 | |
| Jun 7, 2023 | M. Gay John | Executive | Payment | 20,669 | $N/A | $0 | |
| Apr 7, 2022 | L. Bierman James | Executive | Purchase | 1,000 | $3.45 | $3.5K | |
| Mar 28, 2022 | L. Bierman James | Executive | Purchase | 1,000 | $3.45 | $3.5K | |
| Mar 25, 2022 | L. Bierman James | Executive | Purchase | 2,000 | $3.55 | $7.1K | |
| Mar 18, 2022 | M. Gay John | Executive | Purchase | 1,000 | $3.50 | $3.5K | |
| Mar 18, 2022 | W. Palmour John | Executive | Purchase | 10,000 | $3.64 | $36.4K | |
| Mar 17, 2022 | W. Palmour John | Executive | Purchase | 5,000 | $3.34 | $16.7K | |
| Mar 16, 2022 | W. Palmour John | Executive | Purchase | 5,000 | $3.34 | $16.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 87 | $28.1M | 43.2% |
Sale(S) | 98 | $20.7M | 31.8% |
Tender(U) | 11 | $8.8M | 13.5% |
Exercise(M) | 50 | $6.3M | 9.7% |
Disposition(D) | 8 | $1.1M | 1.8% |
Payment(F) | 2 | $44.9K | 0.1% |
Conversion(C) | 10 | $0 | 0.0% |
Award(A) | 29 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider activity at NOVEN PHARMACEUTICALS INC shows mixed signals across all time. While $28.1M in purchases indicates some executive confidence,$20.7M in sales balances the picture, resulting in a modest net flow of $7.4M.40 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Capital Management Oss, has transacted $15.6M during this period.